Skip to content
Dose Brief
Menu

Briefs · page 2 of 13

Every desk on the board, scored

Each GLP-1 telehealth desk we track, graded on the Brief Score — price stability, supply reliability, transparency and access.

Showing 4180 of 495. Most recent verification in the roster: .

Grade B

Solid desks with a trade-off worth reading first.

Grade C and below

Tracked and scored — read the caveats.

Brief Scores are our editorial judgment per the methodology; facts reflect each desk's public disclosures at last check. A commission never changes a score, and it never softens what we write about a desk — see our disclosure. Not medical advice.

The desk's No. 41 · 81/100

Mochi Health

A recognizable coaching-forward brand, but availability is capped at roughly 15 states.

Semaglutide
$138/mo
Tirzepatide
$238/mo
Visit Mochi Health
Full brief →Ad disclosure — we may earn a commission.

Shopping on price?

See every desk with its price direction and the note behind it.

Open the board →